Managers' transactions

A manager (a member of the Board of Directors, CEO or a member of the Management Team) and persons closely associated with them must notify the company and Finnish Financial Supervisory Authority of any transactions they conclude with Nightingale Health's financial instruments without delay and at the latest within three (3) working days of the said transactions (T+3).

The notification to the Finnish Financial Supervisory Authority must be made via the Finnish Financial Supervisory Authority’s electronic services in accordance with the instructions set out on the Finnish Financial Supervisory Authority’s website.

The form submitted to the Finnish Financial Supervisory Authority must be sent to the company to the following email address: trading@nightingalehealth.com.

Nightingale Health will publish the transaction notifications it receives by publishing a company release without delay and no later than two (2) business days after receipt of notification of the transactions from a manager or a person closely associated with them (T+2).

The above-mentioned obligations are based on the EU Market Abuse Regulation ((EU) 596/2014).

Further information and instructions for the notification can be found here: https://www.finanssivalvonta.fi/en/regulation/regulatory-framework/market-abuse-regulation/managers-transactions/

Information needed on the notification:

Nightingale Health Plc’s LEI code: 743700WUIPC24LVMLO66

ISIN codes of Nightingale Health Plc's shares:

· Series B shares: FI4000490875

· Series A shares: FI4000490867

· EMP shares: FI4000490883

Notification reference: Generated automatically (no need to fill in) 

Releases related to transactions of managers can be found here.